about
Natural regression of fibrosis in chronic hepatitis BVirological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic InfectionPrognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia.Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan AfricaClinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units.Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists.Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach.Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBVCost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?Idiopathic portal hypertension in an "inactive" HBV carrier: a case report.Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of iran) in 2012.Molecular characteristics and stages of chronic hepatitis B virus infectionSerologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon.Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.Seroprevalence of Hepatitis B and C markers at the population level in the municipality of Caxias do Sul, southern BrazilInactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study.The management of chronic hepatitis B in Asian Americans.Immunopathogenesis of chronic hepatitis B.Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.Current treatment of hepatitis B virus infections.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literature.The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.Chronic idiopathic normocytic anaemia in older people: the risk factors and the role of age-associated renal impairment.Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.Decrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates.Genotypic polymorphisms of hepatitis B virus provide useful information for estimating geographical origin or place of long-term residence of unidentified cadavers.Molecular characterization of the hepatitis B virus in autochthonous and endogenous populations in the Western Brazilian Amazon.Hepatitis B inactive carriers: clinical course and outcomes.Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon.Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?Update on global epidemiology of viral hepatitis and preventive strategies
P2860
Q26746929-D29BD235-CCD3-49E9-A02B-F77467991B72Q28550977-3D031C4A-524C-46D5-B8BB-7F76064B1FFFQ33580037-83A368E1-3421-4504-8A1B-891BEE45B2E8Q33723314-BE908B6B-4CCE-4C90-B902-454537BF2B86Q33815159-CCEF6241-B99C-43F8-A4D5-D7FD5614F9EAQ33977147-2B56E2F1-35F9-4169-BFB5-55B09B024B3CQ34019908-A5AC92B2-8C2B-4790-B75F-5C8B99C9E884Q35422530-D7DB1CB4-AE8F-4E75-8800-62F73C31B9A9Q35507407-2F9881F3-446D-452C-9D72-6C57A957F945Q36250930-8CDF199A-DDAA-4AFB-88AD-41820FA00F35Q36946816-BD73D446-EE50-482E-9FD3-E46D7A0F3625Q37239898-BDADAB05-16DB-4356-BD8A-5518D75D47FFQ37250341-09127BB7-9BBD-4801-A186-3859055E9363Q37355830-54701DD4-E43E-4440-B179-A2ECF58C1664Q37383718-66709CB2-55A6-4903-A0EE-BE8DFB44083AQ37644212-FB5880E8-302E-4CEA-A58D-91647AEEBB4CQ37711325-FEFA9D81-BEED-49E3-9B77-31CB28269A7DQ37936321-F6A7EE29-8FA0-4C9B-BE8D-293D673B9B4EQ38262108-5D4A4477-4486-401A-BC5F-96E5849F805BQ38539281-E78F0F07-8F9B-49DA-A81F-BFF81BF11330Q38553056-72B524A4-0F4B-49B6-A89C-773C0E8C9290Q38793776-BFEE8EB5-49C6-4F66-8DC1-2886724A8C26Q39140348-1C1A4B3B-C072-4097-97CA-CDC6F3594B97Q40699496-CC352C3A-8288-4A4E-8FCA-E0DBF21445B1Q40821383-F17B2043-F0BA-45A6-BCEB-1D0C7EE8AA2DQ41463829-979FF330-6050-48E3-A3E5-35B50B3BBC1CQ41967380-76622859-6369-4708-9651-6F83C4AC8FE4Q42270997-1F53B8F9-3C92-48B6-9433-0329C2B84D92Q43578077-50F355A1-357E-40AB-B8E0-6191168ABA35Q45292056-3B0026F7-ECC1-40BB-B8FB-A473431F9300Q47552957-B408EE5A-A78D-4CFD-9A61-36E1110658B4Q50998161-FAAF337C-E678-4B3A-812C-94792D74C72AQ59133434-EFA27030-EEE0-4A8A-BA8D-F9C954DF5811
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatitis B virus: inactive carriers
@ast
Hepatitis B virus: inactive carriers
@en
Hepatitis B virus: inactive carriers
@nl
type
label
Hepatitis B virus: inactive carriers
@ast
Hepatitis B virus: inactive carriers
@en
Hepatitis B virus: inactive carriers
@nl
prefLabel
Hepatitis B virus: inactive carriers
@ast
Hepatitis B virus: inactive carriers
@en
Hepatitis B virus: inactive carriers
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Hepatitis B virus: inactive carriers
@en
P2093
Nitin Saini
Sanjeev Kumar Sharma
Yogesh Chwla
P2860
P2888
P3181
P356
10.1186/1743-422X-2-82
P407
P5008
P577
2005-09-28T00:00:00Z
P5875
P6179
1028043439